Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,644 public trials 847 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Active, Not Recruiting

Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies

NCT05270057

Conditions
B-cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • University of Texas Southwestern Dallas, Texas, United States
  • University of Wisconsin School of Medicine and Public Health Madison, Wisconsin, United States
  • Froedtert Hospital & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Active, Not Recruiting

Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia

NCT02153580

Conditions
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma, B-Cell Prolymphocytic Leukemia, Burkitt Lymphoma, +43 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View Trial Details
Active, Not Recruiting

Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial

NCT05556720

Conditions
Blood Protein Disorders, COVID-19 Vaccines, Cardiovascular Diseases, +27 more
Locations
  • St Vincents Hospital Darlinghurst, New South Wales, Australia
  • Prince Of Wales Hospital Randwick, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • Royal Brisbane and Womens Hospital Herston, Queensland, Australia
View all 13 locations
View Trial Details
Active, Not Recruiting

Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)

NCT05878184

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +21 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • University of Kansas Medical Center Fairway, Kansas, United States
View Trial Details
Active, Not Recruiting

Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

NCT04606433

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
View Trial Details

Related conditions